Exploring the prevalence of substance-induced neurocognitive disorder among polysubstance users, adding subjective and objective evidence of cognitive impairment.


Journal

Psychiatry research
ISSN: 1872-7123
Titre abrégé: Psychiatry Res
Pays: Ireland
ID NLM: 7911385

Informations de publication

Date de publication:
06 2020
Historique:
received: 28 05 2019
revised: 23 03 2020
accepted: 24 03 2020
pubmed: 28 4 2020
medline: 4 11 2020
entrez: 28 4 2020
Statut: ppublish

Résumé

The objective of this study was to explore the prevalence of substance-induced neurocognitive disorder (NCD) in a sample of polysubstance users, adding both objective- and subjective cognitive impairment. We collected cross-sectional data from 33 community-based residential facilities in Mexico City. Montreal Cognitive Assessment was used for measurement of objective cognitive impairment, and a DSM-5-based interview for subjective impairment. Years and days of recent use of alcohol, marijuana, cocaine and inhalants were collected for regression analyses. 753 participants were analyzed; from these, 50.5% show objective impairment, 71% and 58.5% self-reported any cognitive deficit and cognitive decline, respectively. Between 21.8%-36.5% would qualify for NCD when integrating both objective- and subjective impairment (deficit or decline). Significant weak associations were found between objective impairment and subjective deficits in all cognitive domains except social cognition. Regression models adding both objective- and subjective measures explained more variation in the years of alcohol, inhalant and cocaine use, and in recent marijuana use, than the objective measure alone, but associations were inconsistent. Though significant in proportion, the prevalence of NCD in this population can only be partially related to substance use. Further integrative approaches are needed to refine the epidemiology of this disorder.

Identifiants

pubmed: 32339804
pii: S0165-1781(19)31183-7
doi: 10.1016/j.psychres.2020.112944
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112944

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interests No conflict declared.

Auteurs

A Toledo-Fernández (A)

Universidad Anáhuac México. Facultad de Psicología. México. Electronic address: aldebaran.toledofe@anahuac.mx.

R Marín-Navarrete (R)

Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz. Unidad de Ensayos Clínicos en Adicciones y Salud Mental. México.

L Villalobos-Gallegos (L)

Universidad Autónoma de Baja California-Tijuana. Facultad de Medicina y Psicología. México.

J Salvador-Cruz (J)

Facultad de Estudios Superiores Zaragoza (FES Zaragoza). Universidad Nacional Autónoma de México. Residencia en Neuropsicología Clínica. México.

C Benjet (C)

Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz. División de Investigaciones Epidemiológicas y Psicosociales. México.

C Roncero (C)

Servicio de Psiquiatría, Complejo Asistencial Universitario de Salamanca. Instituto de Biomedicina de Salamanca. Área de Psiquiatría, Facultad de Medicina, Universidad de Salamanca. España.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH